Today’s issue of WorkCompRecap features the release of a new research report from CompPharma on compounding in workers’ compensation that examines patient safety, efficacy, quality, and cost issues.
The new report, “Compounds in Comp: A New Look at Patient Safety, Efficacy and Cost” notes that its authors are not against the traditional notion of compounding, where medications are combined or altered to create a compound catering to individual patient’s specialized needs. Unfortunately, much of the compounding in workers’ comp isn’t done with patient’s interest in mind, and the paper examines how the AWP has been manipulated to inflate compound prices, among other fraudulent activity. The report also examines regulatory and financial concerns associated with compounding, and looks at each state’s individual regulations and provides recommendations for stakeholders.
Find out more (including a link to the free report!) by clicking here!